scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12026-017-8895-1 |
P698 | PubMed publication ID | 28102512 |
P2093 | author name string | Aiman Natur | |
Levy Yair | |||
Pikman Regina | |||
Rotman Pnina | |||
P2860 | cites work | The role of inflammation in schizophrenia | Q26779719 |
Dysfunction in the coagulation system and schizophrenia | Q28068412 | ||
Association of schizophrenia and autoimmune diseases: linkage of Danish national registers | Q28300105 | ||
Neurological involvement in antiphospholipid antibodies syndrome (APS). | Q33335118 | ||
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies | Q77799413 | ||
Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia | Q84325188 | ||
[Extensive cutaneous necrosis as an initial manifestation of secondary antiphospholipid syndrome (APS)] | Q84741497 | ||
[Psychosis as debut of antiphospholipid syndrome] | Q95383968 | ||
Paediatric case report: primary antiphospholipid syndrome presented with non-thrombotic neurological picture psychosis; treat by antidepressants alone? | Q33389062 | ||
Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures | Q33396284 | ||
High association of anticardiolipin antibodies with psychosis | Q33501832 | ||
Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals | Q33921689 | ||
Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report | Q34504991 | ||
Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis | Q34687562 | ||
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies | Q35189295 | ||
Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment | Q35746924 | ||
Schizophrenia and rheumatoid arthritis: a review | Q36043077 | ||
Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers | Q36234994 | ||
Catatonic Syndrome in Anti-NMDA Receptor Encephalitis | Q36764529 | ||
Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management | Q38021516 | ||
Updating the mild encephalitis hypothesis of schizophrenia | Q38024169 | ||
Risk of venous thromboembolism during treatment with antipsychotic agents | Q38068538 | ||
A systematic, quantitative review of blood autoantibodies in schizophrenia | Q38129587 | ||
The epidemiologic evidence linking autoimmune diseases and psychosis. | Q38160515 | ||
Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study | Q38435398 | ||
NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis? | Q38821460 | ||
Early neuropsychiatric involvement in antiphospholipid syndrome | Q40291856 | ||
Autoimmunity in schizophrenia: a review of recent findings | Q40785380 | ||
Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal | Q40821139 | ||
Increased prevalence of antibrain antibodies in the sera from schizophrenic patients | Q41419057 | ||
Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis | Q42208790 | ||
Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics | Q43837495 | ||
Family history of autoimmune diseases in psychosis | Q44254596 | ||
Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients | Q46112223 | ||
Anti-phospholipid antibodies in cerebrospinal fluid but not serum from a boy with psychosis | Q46255845 | ||
Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients | Q46270431 | ||
Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study | Q46273128 | ||
Psychiatric remission with warfarin: Should psychosis be addressed as plasminogen activator imbalance? | Q48267117 | ||
Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report | Q48301096 | ||
Familial thyroid disease and delayed language development in first admission patients with schizophrenia | Q48693258 | ||
Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study | Q48710157 | ||
A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders | Q50310741 | ||
Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophrenia patients. | Q50634463 | ||
Psychiatric manifestations as a primary symptom in antiphospholipid syndrome. | Q51773681 | ||
Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia | Q58143653 | ||
Psychosis and catatonia as a first presentation of antiphospholipid syndrome | Q60632115 | ||
Obstetric complications and autoantibodies in schizophrenia | Q71633467 | ||
Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia | Q72303293 | ||
Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy | Q72669795 | ||
The antiphospholipid syndrome and psychosis | Q72850832 | ||
The antiphospholipid syndrome | Q77739053 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 438-446 | |
P577 | publication date | 2017-01-19 | |
P1433 | published in | Immunologic Research | Q15754981 |
P1476 | title | Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature | |
P478 | volume | 65 |
Search more.